---
title: "Ubrelvy (ubrogepant) in acute treatment of migraine: Indication questions"
description: "Indication questions on Ubrelvy (ubrogepant) in acute treatment of migraine, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Drug names. Questions: What is Ubrelvy approved for? Can Ubrelvy be used to prevent migraine? What is the generic name of Ubrelvy? When was Ubrelvy first approved in the US? 4 questions quoted from 1 source."
canonical: "https://www.evicenter.com/medical-information/ubrelvy--acute-treatment-of-migraine/indication"
published: "2026-11-14T00:11:41-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Ubrelvy (ubrogepant) in acute treatment of migraine: Indication questions

Manufacturer: AbbVie Inc.  
Prescribing information: [Ubrelvy](https://www.rxabbvie.com/pdf/ubrelvy_pi.pdf)

## Indication

<a id="ubrelvy-indication"></a>

### What is Ubrelvy approved for?

> “UBRELVY is indicated for the acute treatment of migraine with or without aura in adults.”

Source: [UBRELVY: Prescribing information, page 2, captured 2026-11-14](https://www.rxabbvie.com/pdf/ubrelvy_pi.pdf#page=2)

<a id="ubrelvy-migraine-prevention"></a>

### Can Ubrelvy be used to prevent migraine?

> “Limitations of Use  
> UBRELVY is not indicated for the preventive treatment of migraine.”

Source: [UBRELVY: Prescribing information, page 2, captured 2026-11-14](https://www.rxabbvie.com/pdf/ubrelvy_pi.pdf#page=2)

## Drug names

<a id="ubrelvy-generic-name"></a>

### What is the generic name of Ubrelvy?

> “UBRELVY<sup>®</sup> (ubrogepant) tablets, for oral use”

Source: [UBRELVY: Prescribing information, page 1, captured 2026-11-14](https://www.rxabbvie.com/pdf/ubrelvy_pi.pdf#page=1)

> “The active ingredient of UBRELVY is ubrogepant, a calcitonin gene-related peptide (CGRP) 
> receptor antagonist.”

Source: [UBRELVY: Prescribing information, page 8, captured 2026-11-14](https://www.rxabbvie.com/pdf/ubrelvy_pi.pdf#page=8)

<a id="ubrelvy-approval-date"></a>

### When was Ubrelvy first approved in the US?

> “Initial U.S. Approval: 2019”

Source: [UBRELVY: Prescribing information, page 1, captured 2026-11-14](https://www.rxabbvie.com/pdf/ubrelvy_pi.pdf#page=1)

## Related pages
- [Medical information: Ubrelvy (ubrogepant): Acute treatment of migraine](https://www.evicenter.com/medical-information/ubrelvy--acute-treatment-of-migraine)
- [Pharmacology](https://www.evicenter.com/medical-information/ubrelvy--acute-treatment-of-migraine/pharmacology)
- [Clinical trials](https://www.evicenter.com/medical-information/ubrelvy--acute-treatment-of-migraine/clinical-trials)
- [Safety](https://www.evicenter.com/medical-information/ubrelvy--acute-treatment-of-migraine/safety)
- [Specific populations](https://www.evicenter.com/medical-information/ubrelvy--acute-treatment-of-migraine/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/ubrelvy--acute-treatment-of-migraine/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/ubrelvy--acute-treatment-of-migraine/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/ubrelvy--acute-treatment-of-migraine/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/ubrelvy--acute-treatment-of-migraine/access-and-coverage)
